Lumexa Imaging (NASDAQ:LMRI) Shares Up 7.8% – Here’s What Happened

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price rose 7.8% during trading on Thursday . The stock traded as high as $12.60 and last traded at $12.49. Approximately 726,596 shares were traded during trading, a decline of 16% from the average daily volume of 866,732 shares. The stock had previously closed at $11.59.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the stock. Barclays reduced their price objective on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 20th. Wall Street Zen upgraded shares of Lumexa Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Finally, Weiss Ratings upgraded Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research report on Thursday, June 25th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Stock Up 7.1%

The stock has a fifty day simple moving average of $9.04. The company has a debt-to-equity ratio of 1.43, a quick ratio of 1.40 and a current ratio of 1.40.

Insider Buying and Selling

In other Lumexa Imaging news, Director Brett Brodnax bought 35,000 shares of Lumexa Imaging stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the completion of the acquisition, the director owned 62,027 shares in the company, valued at approximately $449,695.75. The trade was a 129.50% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Lumexa Imaging

Hedge funds have recently modified their holdings of the business. Assetmark Inc. bought a new position in shares of Lumexa Imaging during the 4th quarter valued at about $36,000. Strs Ohio acquired a new stake in Lumexa Imaging during the 1st quarter worth approximately $38,000. PNC Financial Services Group Inc. acquired a new stake in Lumexa Imaging during the 1st quarter worth approximately $63,000. State of Wyoming bought a new position in Lumexa Imaging in the first quarter valued at approximately $91,000. Finally, Barclays PLC acquired a new position in shares of Lumexa Imaging in the fourth quarter valued at approximately $133,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).